Introduction
Medical device registration in Japan is the structured regulatory and operational function through which a business determines whether a product is regulated as a medical device under the Japanese framework, identifies the applicable class and secures the approval, certification or notification route required for lawful market entry.
In practical terms, Japan operates through a combination of PMD Act pathway logic, Japanese market-holder structure and regulator split between administrative authority and review authority.
The subject is commercially important because Japan is one of the world’s most significant medtech markets, while mistakes around device class, MAH structure, foreign-manufacturer status or pathway choice can block lawful commercialization.
Home
└── Jurisdictions
└── Japan
└── Medical Device Registration Japan
Identity
- Object: Medical Device Registration
- Jurisdiction: Japan
- Object ID: JP.MDR.001
- Reference: MAR-JP-MDR-001-A
Core Framework
- PMD Act market-entry framework
- MHLW and PMDA split regulatory roles
- MAH-based or Japanese manufacturer-based submission structure
- Class-specific routes through notification, certification or approval
Operating Logic
- Class I to IV risk-based regulation
- Japanese MAH structure is central to foreign market entry
- PMDA review is critical where MHLW approval is required
- Foreign manufacturer accreditation is a separate but connected issue
Executive Summary
Medical device registration in Japan is the professional regulatory and market-access function concerned with determining whether a product qualifies as a medical device under Japanese law, identifying its class and securing the correct PMD Act pathway for lawful commercialization.
Japan uses a two-authority structure. PMDA explains that there are two regulatory authorities responsible for medical devices in Japan: the Ministry of Health, Labour and Welfare and the PMDA. PMDA further explains that MHLW handles administrative actions and approval decisions under the PMD Act, while PMDA undertakes product review and post-market safety measures.
The pathway is class-driven. PMDA states that medical devices in Japan are classified into four classes based on risk, from Class I to Class IV, and that foreign manufacturers must obtain approval, certification or submit notification depending on classification through a Japanese Marketing Authorization Holder or a Japanese manufacturer appointed by the foreign manufacturer.
For foreign market-entry planning, the MAH structure and foreign manufacturer status are central. PMDA provides an English page for Accreditation of Foreign Manufacturers, indicating that foreign-manufacturer recognition operates as a distinct regulatory topic in the Japanese system.
| Definition | The professional regulatory and market-access function concerned with securing the lawful Japanese pathway for medical devices through classification, PMD Act route selection, MAH structure and foreign-manufacturer readiness. |
| Object | Medical Device Registration |
| Object Type | Professional Regulatory and Market-Access Function |
| Classification | Medical Devices, Japan, PMDA, MHLW, PMD Act, MAH, Certification, Approval, Notification, Foreign Manufacturer |
| Jurisdiction | Japan |
Definition
Medical device registration in Japan refers to the structured process through which a business determines whether its product falls within the Japanese medical-device framework, identifies the relevant class and secures the appropriate route of notification, certification or approval through the required Japanese market-holder structure.
The object is broader than filing a dossier. It covers device qualification, class mapping, JMDN-oriented positioning in practice, PMD Act pathway strategy, MAH or designated Japanese holder structure, foreign-manufacturer accreditation and ongoing safety and quality alignment.
| Covered Matters | Device qualification, class determination, pathway selection, PMD Act route analysis, MAH structure, foreign manufacturer accreditation, quality-system readiness and post-market alignment. |
| Functional Boundary | The Registry Object covers how businesses achieve and maintain lawful Japanese market access for medical devices. |
| Related but Not Primary | Reimbursement, hospital procurement, patent strategy, general distributor contracting and broader healthcare commercialization are adjacent but not the primary object here. |
| Outside Scope | Pharmaceutical-only approval, unrelated consumer-product regulation and general company-incorporation matters. |
Scope
The Japanese medical device registration function applies to products regulated as medical devices under the PMD Act and to the market participants needed to bring those devices lawfully into Japan. PMDA states that in order to market medical devices in Japan, a foreign manufacturer has to obtain approval, certification or submit notification depending on the classification through a Japanese MAH or Japanese manufacturer appointed by the foreign manufacturer.
The scope is therefore both product-facing and structure-facing. A correct Japanese analysis must address not only device class but also who will legally hold and manage the pathway in Japan.
Editorial Note: In Japan, a registration review is incomplete if it looks only at the product and ignores the Japanese MAH structure through which the foreign manufacturer must access the market.
Purpose
The purpose of medical device registration in Japan is to convert a product, evidence base and commercial plan into a lawful PMD Act market-entry position.
In business terms, the function exists to identify the correct class-based route, structure the Japanese MAH pathway, determine whether certification or approval is needed and reduce the risk of entering Japan on an unsupported regulatory assumption.
Primary Outcome
A coherent Japanese medical device registration position means that the device has been qualified correctly, matched to the appropriate Class I, II, III or IV route and linked to the Japanese MAH structure required for commercialization.
Depending on the class, the outcome may be a PMDA notification route, certification by a registered certification body or MHLW approval following PMDA review. PMDA states that Class I devices follow notification to PMDA, some Class II and III devices follow certification by a registered certification body and Class IV devices require MHLW approval.
Request Contexts
Request contexts show the business situations in which Japanese registration work is usually activated. Most begin before launch, but the function is also relevant in MAH restructuring, product-change reviews and cross-border transfer projects.
| Identity Pattern | Manufacturer planning Japanese entry, foreign manufacturer evaluating MAH options, regulatory lead reviewing Class I-IV pathway, commercial team assessing certification versus approval route, acquirer validating Japanese registration architecture. |
| Business Event | First Japanese launch, class uncertainty, PMDA consultation planning, certification-body strategy, MHLW approval planning, foreign-manufacturer accreditation, MAH change or portfolio due diligence. |
| Typical User | Manufacturers, Japanese MAHs, designated market holders, regulatory affairs managers, legal advisers, investors and international medtech businesses. |
| Typical Scenario | A company needs to determine whether its product falls into a notification, certification or approval route in Japan, which Japanese MAH structure should be used and whether foreign-manufacturer accreditation and quality-system readiness have been addressed. |
Typical Users
Different actors encounter Japanese registration from different positions, but the common issue is the need for a defensible answer on class, route and Japanese legal holder structure.
| Foreign Manufacturer | Needs to determine class, route, MAH structure and foreign-manufacturer readiness before commercialization. |
| Japanese MAH | Needs to manage the market-entry pathway and ensure efficacy, safety and quality before submission. PMDA states that the MAH must ensure efficacy, safety and quality based on the evidence before submission. |
| Regulatory Affairs Lead | Needs to align class, evidence, quality-system readiness and route strategy with PMD Act requirements. |
| Certification-Route Applicant | Needs to determine whether certification standards exist for the relevant Class II or III device and whether a registered certification body is the correct route. |
| Approval-Route Applicant | Needs to prepare for PMDA review and MHLW approval where certification is not available or the device falls into a higher-risk category. |
Typical Scenarios
Practical scenarios show where Japanese registration analysis becomes operationally important.
| Initial Qualification | The business must determine whether the product is a medical device under the PMD Act framework. |
| Class Strategy | The company needs to determine whether the device falls into Class I, II, III or IV. PMDA states that Japan classifies devices into four risk-based classes. |
| Notification Route | The manufacturer needs to assess whether a Class I notification to PMDA is the correct route. |
| Certification Route | The business needs to check whether certification standards exist so the product can be certified by a registered certification body. |
| Approval Route | The business needs to prepare for PMDA review and MHLW approval where the device falls into approval territory. |
| Foreign Manufacturer Planning | The manufacturer needs to assess foreign-manufacturer accreditation and MAH structure as separate but related readiness issues. |
Jurisdiction Characteristics
Japan is a PMD Act-centered device jurisdiction with a formal split between administrative authority and review authority. PMDA explains that MHLW handles administrative actions and approval decisions, while PMDA undertakes product review and post-market safety measures.
A distinctive practical feature is that foreign market entry requires a Japanese market-holder structure rather than a simple direct overseas filing model. PMDA states that foreign manufacturers must access the market through a Japanese MAH or Japanese manufacturer appointed by the foreign manufacturer.
| Operational Culture | Formal, class-based and strongly structured around Japanese legal-holder responsibility. |
| Legal Framework Orientation | PMD Act pathway logic with role separation between MHLW and PMDA. |
| Commercial Context | Major medtech market where precise route selection and Japanese-language regulatory positioning matter. |
| Language Expectation | Japanese-language regulatory practice is central, even where English summaries are available from PMDA. |
Key Authorities
Japanese medical device registration is centered on the Ministry of Health, Labour and Welfare and the Pharmaceuticals and Medical Devices Agency. PMDA states that these are the two regulatory authorities responsible for medical devices in Japan.
| Official Name | Ministry of Health, Labour and Welfare |
| Official English Name | Ministry of Health, Labour and Welfare (MHLW) |
| Primary Role | Administrative authority responsible for guidance and product-approval decisions under the PMD Act. |
| Responsibilities | Handles administrative actions, product-approval decisions and judgments on whether a product is considered a medical device. |
| Typical Interaction | Important where the route requires approval decisions and formal administrative handling under the PMD Act. |
| Official Website | PMDA Overview of Medical Device Regulations |
| Cross-Border Relevance | High, because foreign manufacturers entering Japan are subject to the MHLW decision structure via Japanese market holders. |
| Official Name | Pharmaceuticals and Medical Devices Agency |
| Official English Name | Pharmaceuticals and Medical Devices Agency (PMDA) |
| Primary Role | Review authority and post-market safety authority for medical devices. |
| Responsibilities | Undertakes product review, post-market safety measures and provides regulatory pathways information for device registration in Japan. |
| Typical Interaction | Direct where a device follows notification, consultation or review-oriented approval pathways, or where foreign-manufacturer topics must be addressed. |
| Official Website | PMDA English |
| Cross-Border Relevance | High, because foreign manufacturers depend on PMDA-facing route analysis, review expectations and regulatory information. |
Applicable Legislation
The Japanese framework is anchored in the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices, referred to by PMDA as the PMD Act. PMDA explains that MHLW approval decisions and PMDA review activities are conducted pursuant to that Act.
| Official Title | Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices |
| Year | Current Japanese framework |
| Purpose | Provides the legal framework for classifying, reviewing, certifying, approving and monitoring medical devices in Japan. |
| Typical Application | Used to determine whether the device falls into notification, certification or approval territory and how it must be commercialized in Japan. |
| Related Legislation | Ministerial ordinances, quality-system rules and criteria for certification or approval under the PMD Act framework. |
| Official Source | Regulations and Approval/Certification of Medical Devices |
| Current Status | Active framework. |
| Official Title | Foreign Manufacturer Accreditation Framework |
| Year | Current PMDA/MHLW regulatory topic |
| Purpose | Addresses accreditation of foreign manufacturers as part of Japanese cross-border device market-entry readiness. |
| Typical Application | Used when overseas manufacturing sites or foreign manufacturers need to be recognized in the Japanese system. |
| Related Legislation | PMD Act implementation materials and foreign-manufacturer procedures. |
| Official Source | Accreditation of Foreign Manufacturers |
| Current Status | Active regulatory topic. |
Process Flow
Japanese medical device registration normally works as a staged process from device qualification to commercialization. PMDA’s official framework starts with class determination and then links the product to notification, certification or approval depending on classification and available standards.
| 1. Product Qualification | Determine whether the product is a medical device under the PMD Act framework. |
| 2. Class Determination | Identify the applicable Class I, II, III or IV category. |
| 3. MAH Structure | Appoint or align the Japanese MAH or Japanese manufacturer structure required for foreign market entry. |
| 4. Certification-Standards Review | For Class II and III products, determine whether certification standards exist and whether certification by a registered certification body is possible. |
| 5. Foreign Manufacturer Readiness | Address foreign-manufacturer accreditation and related facility readiness where applicable. |
| 6. Submission Pathway | Proceed with PMDA notification, certification-body submission or approval-oriented filing depending on the class route. |
| 7. PMDA Review or Certification | Where approval is needed, PMDA conducts product review and MHLW makes the approval decision; where certification applies, a registered certification body handles the certification route. |
| 8. Market Launch | Commercialize the device only after the applicable Japanese legal position is in place. |
| 9. Post-Market Maintenance | Maintain safety, quality and post-market obligations after entry. |
| Typical Outputs | Qualification memo, class rationale, MAH structure file, foreign-manufacturer readiness file, notification/certification/approval dossier and post-market controls. |
Decision Tree
The decision tree helps simplify the main Japanese threshold questions.
- Confirm whether the product is a medical device under the Japanese framework.
- Determine the risk class because Japan uses a four-class system from Class I to Class IV.
- Establish the Japanese MAH or equivalent legal-holder structure through which the foreign manufacturer will access the market.
- If the product is Class I, determine whether notification to PMDA is the relevant route.
- If the product is Class II or III, determine whether certification standards exist and whether certification by a registered certification body is available.
- If certification is not available or the product falls into approval territory, prepare for PMDA review and MHLW approval.
- Address foreign-manufacturer accreditation and quality-system readiness as needed.
- Commercialize only after the correct Japanese legal position is secured.
Timeline
The Japanese timeline begins before launch and continues after commercialization. The exact route depends on device class, the existence of certification standards and the Japanese legal-holder structure used for entry.
| Concept Stage | The business defines the product, intended use and Japanese market objective. |
| Qualification Stage | The product is assessed to determine whether it is a medical device under the PMD Act. |
| Classification Stage | The class is mapped because it drives the pathway. |
| Structure Stage | The Japanese MAH or equivalent legal-holder arrangement is put in place. |
| Readiness Stage | Foreign-manufacturer and quality-system readiness are addressed where relevant. |
| Submission Stage | The business proceeds with notification, certification or approval work according to class. |
| Launch Stage | The device is commercialized only after the relevant Japanese route is complete. |
| Maintenance Stage | The business and MAH maintain post-market safety and quality obligations. |
Required Documents
The exact document set depends on class and pathway, but Japanese medical device registration depends on a coherent set of materials that supports class strategy, route selection and Japanese legal-holder readiness.
| Document | Product Qualification and Classification Record |
| Purpose | Explains why the product is a medical device in Japan and what class applies. |
| Typical Situation | Prepared at the beginning of Japanese registration strategy. |
| Document | MAH Structure File |
| Purpose | Documents the Japanese MAH or Japanese manufacturer structure through which the product will be commercialized. |
| Typical Situation | Used whenever a foreign manufacturer plans Japanese market entry. |
| Document | Foreign Manufacturer Accreditation File |
| Purpose | Supports accreditation or readiness for foreign manufacturing sites where the Japanese system requires it. |
| Typical Situation | Used in cross-border Japanese market-entry projects involving overseas manufacturing. |
| Document | Certification or Approval Dossier |
| Purpose | Supports certification by a registered certification body or PMDA-reviewed approval as required by class. |
| Typical Situation | Used where the product is not handled through a simple notification route. |
| Document | Post-Market Safety and Quality File |
| Purpose | Supports continuing safety, quality and market maintenance after launch. |
| Typical Situation | Maintained after commercialization in Japan. |
Cross-Border Relevance
Cross-border relevance is high because many non-Japanese manufacturers rely on the Japanese MAH model to enter the market. PMDA states that foreign manufacturers must obtain the required pathway through a Japanese MAH or Japanese manufacturer appointed by the foreign manufacturer.
Foreign-manufacturer status is also a distinct readiness issue. PMDA provides a separate official page dedicated to accreditation of foreign manufacturers, which indicates that cross-border manufacturing status is not merely an internal administrative detail.
| Recognition | Japanese market access depends on PMD Act pathway compliance and Japanese holder structure rather than automatic recognition of overseas approval. |
| Foreign Companies | Foreign manufacturers must structure entry through a Japanese MAH or appointed Japanese manufacturer. |
| Language Considerations | Japanese-language materials and market practice are central to successful registration and commercialization. |
| International Rules | Cross-border businesses must treat foreign-manufacturer accreditation and local-holder structure as core regulatory workstreams. |
| Practical Considerations | Japanese entry strategy should treat class, route, MAH structure and foreign-manufacturer readiness as one integrated architecture. |
| Typical Risk | Assuming that a global approval strategy can be transferred into Japan without reworking the pathway through Japanese class and holder logic. |
PMDAMHLWPMD ActMAHForeign ManufacturerCertificationApproval
Operating Constraints & Risks
Operating constraints identify the recurring failure points in Japanese medical device registration. Many arise when businesses underestimate how structural the Japanese MAH and class system is.
| Qualification Risk | The product is misread as a medical device or non-device under the Japanese framework. |
| Class Risk | The wrong class is assumed, leading to the wrong route between notification, certification and approval. |
| Structure Risk | The Japanese MAH model is not set up correctly before regulatory work starts. |
| Foreign Manufacturer Risk | Accreditation or facility-readiness issues are ignored until late in the process. |
| Certification Risk | The business assumes certification standards exist when the product may actually require approval. |
| Approval Risk | The company underestimates the PMDA review burden and MHLW approval route for higher-risk products. |
| Language and Documentation Risk | Japanese-language and local-format expectations are underestimated, delaying the route to market. |
Costs & Fees
Japanese medical device registration costs arise from several separate components rather than one single filing step. Class strategy, MAH structure, review interactions and foreign-manufacturer readiness all contribute to overall cost.
| Assessment Costs | Classification analysis, route planning and documentation strategy can be substantial depending on device complexity. |
| MAH Costs | The Japanese MAH or market-holder structure often creates ongoing commercial and compliance cost because it is central to market entry. |
| Review Costs | PMDA notes that face-to-face consultation meetings for approval-oriented products are fee-applicable. |
| Certification Costs | Where a certification-body route applies, certification preparation and external review create direct and indirect costs. |
| Foreign Manufacturer Costs | Foreign-manufacturer accreditation and facility-readiness work can add significant project cost. |
| Maintenance Costs | Post-market safety, quality and legal-holder maintenance create continuing expense. |
FAQ
The FAQ section addresses recurring threshold questions in Japanese market-entry work.
| Who Regulates Medical Devices in Japan? | PMDA states that the two regulatory authorities are MHLW and PMDA. MHLW handles administrative actions and approval decisions, while PMDA undertakes product review and post-market safety measures. |
| How Many Device Classes Does Japan Use? | Japan uses four device classes, from Class I to Class IV, based on risk. |
| Can a Foreign Manufacturer File Directly Without a Japanese Holder? | No. PMDA states that foreign manufacturers market medical devices in Japan through a Japanese MAH or a Japanese manufacturer appointed by the foreign manufacturer. |
| Do All Devices Need MHLW Approval? | No. PMDA states that some devices are handled by notification or certification, while higher-risk or other non-certifiable products require MHLW approval. |
| Is Foreign Manufacturer Accreditation a Separate Issue? | Yes. PMDA provides a distinct regulatory page on accreditation of foreign manufacturers, which indicates it is handled as a separate topic in the Japanese system. |
| Does Registration End After Launch? | No. PMDA identifies post-market safety measures as part of the Japanese medical-device system. |
Practical Guidance
Practical guidance helps a business prepare before finalising a Japanese market-entry strategy.
| Checklist | What exactly is the product under Japanese law? What class applies? Is the route notification, certification or approval? Do certification standards exist for the relevant class? Who will act as the Japanese MAH or appointed Japanese manufacturer? Has foreign-manufacturer accreditation or readiness been reviewed? Has the business prepared for PMDA review or consultation where approval may be required? Are safety, quality and post-market maintenance responsibilities clearly allocated? Has the Japanese-language regulatory strategy been considered from the start? |
A disciplined Japanese registration review should start with class and holder structure. In many failed launches, the visible approval problem is only a later symptom of an earlier error about who legally holds the route in Japan, what class the device belongs to or whether the foreign manufacturer is truly ready for the Japanese system.
Jurisdictional Expert
The Jurisdictional Expert section records the status of the registry position associated with this jurisdictional object. It remains separate from the editorial content.
| Registry Position ID | RE-JP-MDR-001 |
| Registry Position | Jurisdictional Expert Medical Device Registration Japan |
| Registry Availability | Open |
| Verification Status | No verified participant currently assigned to this registry position. |
| Coverage | Japan medical device registration with emphasis on PMD Act pathways, PMDA and MHLW roles, Japanese MAH structure and foreign-manufacturer readiness. |
| Registry Reference | MAR-JP-MDR-001-A Jurisdictional Expert Position |
| Contact Information | Registry position not yet assigned. |
Machine Layer
This section contains machine-oriented registry fields retained for indexing, retrieval, system organisation and future rendering control. It may be visually minimised while remaining fully available in the HTML source.
| Object DNA | medical device registration japan pmda mhlw pmd act mah notification certification approval foreign manufacturer class i class ii class iii class iv market access |
| AI Retrieval Summary | Neutral registry object describing how medical device registration operates in Japan, including PMD Act pathway selection, PMDA and MHLW roles, Japanese MAH structure, class-based notification certification approval routes and foreign-manufacturer readiness. |
| Entity Index | Japan Medical Device Registration PMDA MHLW PMD Act MAH Notification Certification Approval Foreign Manufacturer |
| Machine Metadata | Registry rendering layer https://market-access-records.org/css/registry.css | Object ID JP.MDR.001 | Machine Reference MAR-JP-MDR-001-A | Internal Classification Business > Regulatory & Market Access > Medical Device Registration > Japan | Checksum 0xMDR91JP |
| Internal References | Registry Object | Jurisdiction Node | Editorial Record | Jurisdictional Expert Position | Machine-readable Reference Node |